Arcturus Therapeutics (ARCT) Prices 3.26M Share Common Offering at $53/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
After-Hours Movers 07/28: (BGFV) (KODK) (AMD) Higher; (KODK) (RRD) (STX) Lower (more...)
July 28, 2020 6:04 PM EDTToday's After-Hours Movers
Big 5 Sporting Goods (NASDAQ: BGFV) 47% HIGHER; reported Q2 EPS of $0.52, versus $0.00 reported last year. Revenue for the quarter came in at $227.94 million, versus $240.97 million reported last year.
Eastman Kodak Company (NYSE: KODK) 36% HIGHER; adds to 200%+ intra-day gains as Trump mentioned the deal to produce drug ingredients
Community Health Systems (NYSE: CYH) 16.5% HIGHER; reported Q2 EPS of $0.85, $1.47 better than the analyst estimate of ($0.62). Revenue for... More
Arcturus Therapeutics (ARCT) Announces Proposed Public Offering of Common Stock
July 28, 2020 4:15 PM EDTArcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares... More
Arcturus Therapeutics (ARCT) PT Raised to $78 at H.C. Wainwright
July 27, 2020 6:36 AM EDTH.C. Wainwright analyst Ed Arce raised the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $78.00 (from $62.00) while maintaining a Buy rating.... More



